Trial Site Detail

 

Drug:
Entrectinib
Trial:
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Fusions) (STARTRK-2)
Conditions: Sarcoma
Trial Status:
Recruiting

 

Arthur G. James Cancer Hospital

300 W. 10th Ave.     
Columbus , OH 43210
USA

 

Principal Investigator:
Contact:
Contact: Gregory Otterson, MD
Activation Status of this Site:
Active
Notes about this Site:
Arthur G. James Cancer Hospital Website:
http://cancer.osu.edu/patientsandvisitors/Pages/index.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.